The German Aortic Valve Registry: 1-year results from 13 680 patients with aortic valve disease†
Friedrich W. Mohr(Leipzig Heart Institute), Christian W. Hamm(Justus-Liebig-Universität Gießen), Karl‐Heinz Kück(University Hospital Schleswig-Holstein), Jochen Cremer(Christian-Albrechts-Universität zu Kiel), David Holzhey, Thomas Walther(Goethe University Frankfurt), Gerhard Schüler(Institut de Médecine de la Reproduction), Christof Veit(Justus-Liebig-Universität Gießen), Ralf Zahn(Klinikum Ludwigshafen), Till Neumann(University of Duisburg-Essen), Konstantinos Papoutsis(Justus-Liebig-Universität Gießen), Gerd Heusch(West German Heart and Vascular Center Essen), Friedhelm Beyersdorf(University of Freiburg), Rüdiger Lange(German Centre for Cardiovascular Research), Steffen Schneider(Klinikum Ludwigshafen), Stefan Sack(München Klinik Schwabing), Hans R. Figulla(German Cardiac Society), Thomas Meinertz(Universität Hamburg), Andreas Beckmann(German Society for Thoracic and Cardiovascular Surgery), Anne-Kathrin Funkat(Leipzig Heart Institute), Michael Böhm(Saarland University), Armin Welz(University of Bonn), Helge Möllmann(St.-Johannes-Hospital Dortmund)
Cited by 166
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k